Skip to product information
1 of 1

Recent Advances in Innovative Magnetic Nanomaterials for Cancer Theranostics

Regular price £35.50
Sale price £35.50 Regular price £35.50
Sale Sold out
This book provides a detailed overview of cancer theranostics applications of magnetic iron oxide nanoparticles. Their synthesis, characterization, multifunctionality, disease targeting, biodistrib...
Read More
  • Format:
  • 29 October 2019
View Product Details

This book provides a detailed overview of cancer theranostics applications of magnetic iron oxide nanoparticles. Their synthesis, characterization, multifunctionality, disease targeting, biodistribution, pharmacokinetics and toxicity are highlighted, along with current examples of clinical trials of magnetic nanoparticles in cancer theranostics, and their future scopes and challenges.

files/i.png Icon
Price: £35.50
Publisher: Morgan & Claypool Publishers
Imprint: Morgan & Claypool Publishers
Publication Date: 29 October 2019
Trim Size: 10.00 X 7.00 in
ISBN: 9780750330206
Format: Paperback
BISACs:

MEDICAL / Nursing / Oncology & Cancer, Medical physics, TECHNOLOGY & ENGINEERING / Materials Science / General, Materials / States of matter

REVIEWS Icon

Table of Contents

Chapter 1: Introduction

1.1. Cancer and statistics

1.2. Conventional therapies for cancer and their limitations

1.3. Alternative theranostics strategy: Nanomedicine

1.4. Magnetic nanoparticles and cancer theranostics

Chapter 2: Magnetic nanoparticles: Types, synthesis and characterization

2.1 Common types of magnetic nanomaterials and their synthesis

2.2 Characterization techniques

2.3 Multilayer concept

Chapter 3: Magnetic nanoparticles for cancer diagnostics

3.1. MRI

3.2. Multimodal imaging

3.3. Biosensors

3.4. Cell labeling

Chapter 4: Magnetic nanoparticles for cancer therapeutics

4.1. Drug delivery: Chemotherapeutics, Biotherapeutics and Radiotherapeutics

4.2. Magnetic Hyperthermia

4.3. Photodynamic therapy

4.4. Photothermal ablation

4.5. MNPs as Anticancer agent

4.6. MNPs in Cancer Immunotherapy

Chapter 5: Safety of Magnetic nanomaterials, Challenges, future scope and Conclusion

5.1. Pharmacokinetics, biodistribution, toxicity

5.2. Targeting

5.3. Magnetic nanoparticles as FDA approved or in clinical trials

5.4. Challenges, future scopes and conclusion